128 related articles for article (PubMed ID: 10567850)
21. Thyroid function and thyroxine metabolism in hexachlorobenzene-induced porphyria.
Kleiman de Pisarev DL; Rios de Molina MC; San Martin de Viale LC
Biochem Pharmacol; 1990 Mar; 39(5):817-25. PubMed ID: 2310407
[TBL] [Abstract][Full Text] [Related]
22. Stimulation of liver heme oxygenase in hexachlorobenzene-induced hepatic porphyria.
Stonard MD; Poli G; De Matteis F
Arch Toxicol; 1998 May; 72(6):355-61. PubMed ID: 9657283
[TBL] [Abstract][Full Text] [Related]
23. Hexachlorobenzene impairs glucose metabolism in a rat model of porphyria cutanea tarda: a mechanistic approach.
Mazzetti MB; Taira MC; Lelli SM; Dascal E; Basabe JC; de Viale LC
Arch Toxicol; 2004 Jan; 78(1):25-33. PubMed ID: 12898129
[TBL] [Abstract][Full Text] [Related]
24. Studies on the mechanism of uroporphyrinogen decarboxylase inhibition in hexachlorobenzene-induced porphyria in the female rat.
Mylchreest E; Charbonneau M
Toxicol Appl Pharmacol; 1997 Jul; 145(1):23-33. PubMed ID: 9221820
[TBL] [Abstract][Full Text] [Related]
25. Cytochrome P450 induction, uroporphyrinogen decarboxylase depression, porphyrin accumulation and excretion, and gender influence in a 3-week rat model of porphyria cutanea tarda.
Franklin MR; Phillips JD; Kushner JP
Toxicol Appl Pharmacol; 1997 Dec; 147(2):289-99. PubMed ID: 9439724
[TBL] [Abstract][Full Text] [Related]
26. Immunochemical studies of the uroporphyrinogen decarboxylase defect caused by hexachlorobenzene.
Elder GH; Urquhart AJ
IARC Sci Publ; 1986; (77):441-8. PubMed ID: 3596736
[TBL] [Abstract][Full Text] [Related]
27. The effect of bleeding and iron administration on the development of hexachlorobenzene-induced rat porphyria.
Blekkenhorst GH; Day RS; Eales L
Int J Biochem; 1980; 12(5-6):1013-7. PubMed ID: 7450111
[No Abstract] [Full Text] [Related]
28. The role of iron in the hexachlorobenzene induced porphyria. I. Studies on different types of iron and its relation with porphyrinogen carboxy-lyase decrease.
Wainstok de Calmanovici R; Ríos de Molina MC; San Martín de Viale LC
Acta Physiol Pharmacol Latinoam; 1985; 35(4):481-91. PubMed ID: 2940809
[TBL] [Abstract][Full Text] [Related]
29. Immune effects of hexachlorobenzene in the rat: role of metabolism in a 13-week feeding study.
Schielen P; Den Besten C; Vos JG; Van Bladeren PJ; Seinen W; Bloksma N
Toxicol Appl Pharmacol; 1995 Mar; 131(1):37-43. PubMed ID: 7878676
[TBL] [Abstract][Full Text] [Related]
30. Porphyrinogenic effect of hexachlorobenzene and 2,3,7,8-tetrachlorodibenzo-para-dioxin: is an inhibitor involved in uroporphyrinogen decarboxylase inactivation?
Cantoni L; Graziani A; Rizzardini M; Saletti MC
IARC Sci Publ; 1986; (77):449-56. PubMed ID: 3596737
[TBL] [Abstract][Full Text] [Related]
31. Phospholipid alterations elicited by hexachlorobenzene in rat brain are strain-dependent and porphyria-independent.
Cochón AC; San Martín de Viale LC; Billi de Catabbi SC
Comp Biochem Physiol C Toxicol Pharmacol; 2001 Oct; 130(2):199-207. PubMed ID: 11574289
[TBL] [Abstract][Full Text] [Related]
32. Sex-linked hepatic uroporphyria and the induction of cytochromes P450IA in rats caused by hexachlorobenzene and polyhalogenated biphenyls.
Smith AG; Francis JE; Green JA; Greig JB; Wolf CR; Manson MM
Biochem Pharmacol; 1990 Nov; 40(9):2059-68. PubMed ID: 2173599
[TBL] [Abstract][Full Text] [Related]
33. Effects of the porphyrinogenic compounds hexachlorobenzene and 3,5-diethoxycarbonyl-1,4-dihydrocollidine on polyamine metabolism.
Cochón AC; González N; San Martín de Viale LC
Toxicology; 2002 Jul; 176(3):209-19. PubMed ID: 12093617
[TBL] [Abstract][Full Text] [Related]
34. Relative abilities on a molar basis of hexafluoro-, hexachloro- and hexabromobenzenes to decrease liver uroporphyrinogen decarboxylase activity and cause porphyria in female rats.
Smith AG; Francis JE
Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):377-84. PubMed ID: 7394329
[TBL] [Abstract][Full Text] [Related]
35. Development of an experimental model for the study of hexachlorobenzene-induced hepatic porphyria in the rat.
Krishnan K; Brodeur J; Charbonneau M
Fundam Appl Toxicol; 1991 Oct; 17(3):433-41. PubMed ID: 1794647
[TBL] [Abstract][Full Text] [Related]
36. Studies on the toxicology of hexachlorobenzene. V. Different phases of porphyria during and after treatment.
Koss G; Seubert S; Seubert A; Seidel J; Koransky W; Ippen H
Arch Toxicol; 1983 Jan; 52(1):13-22. PubMed ID: 6838374
[No Abstract] [Full Text] [Related]
37. Genetic, iron status and sex factors of porphyria induced by hexachlorobenzene.
Smith AG; Stewart FP; Francis JE
IARC Sci Publ; 1986; (77):433-9. PubMed ID: 3596735
[TBL] [Abstract][Full Text] [Related]
38. Effects of hexachlorobenzene feeding and iron overload on enzymes of haem biosynthesis and cytochrome P 450 in rat liver.
Louw M; Neethling AC; Percy VA; Carstens M; Shanley BC
Clin Sci Mol Med; 1977 Aug; 53(2):111-5. PubMed ID: 891100
[TBL] [Abstract][Full Text] [Related]
39. Effect of alpha lipoic acid amide on hexachlorobenzene porphyria.
Vilas GL; Aldonatti C; San Martín de Viale LC; Ríos de Molina MC
Biochem Mol Biol Int; 1999 May; 47(5):815-23. PubMed ID: 10365252
[TBL] [Abstract][Full Text] [Related]
40. The effect of the porphyrogenic compound, hexachlorobenzene, on the activity of hepatic uroporphyrinogen decarboxylase in the rat.
Elder GH; Evans JO; Matlin SA
Clin Sci Mol Med; 1976 Jul; 51(1):71-80. PubMed ID: 939068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
